Incidence, Clinical Features, and Outcome of AllTrans-Retinoic Acid Syndrome in 413 Cases of Newly Diagnosed Acute Promyelocytic LeukemiaStéphane de Botton, the European APL Group, Hervé Dombret et al.|Blood|1998Cited by 338
Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemiaKheïra Beldjord, Hervé Dombret, Vahid Asnafi et al.|Blood|2014Cited by 327
Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemiaNathalie Dhédin, Norbert Ifrah, Anne Huynh et al.|Blood|2015Cited by 270
Prognostic Impact of Isocitrate Dehydrogenase Enzyme Isoforms 1 and 2 Mutations in Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association GroupNicolas Boissel, Claude Preudhomme, Olivier Nibourel et al.|Journal of Clinical Oncology|2010Cited by 218
Autologous and Allogeneic Stem-Cell Transplantation As Salvage Treatment of Acute Promyelocytic Leukemia Initially Treated With All-<i>Trans</i>-Retinoic Acid: A Retrospective Analysis of the European Acute Promyelocytic Leukemia GroupStéphane de Botton, Pierre Fenaux, A Fawaz et al.|Journal of Clinical Oncology|2004Cited by 135